Real-world treatment patterns and clinical outcomes for patients with deficient mismatch repair (dMMR) metastatic colorectal cancer (mCRC).
Vanessa Wong(Walter and Eliza Hall Institute of Medical Research), Peter Gibbs(Walter and Eliza Hall Institute of Medical Research), Hiren Mandaliya(Lake Macquarie Private Hospital), Matthew Loft(Walter and Eliza Hall Institute of Medical Research), T. J. Hayes(St John of God Hospital), Azim Jalali(Walter and Eliza Hall Institute of Medical Research), Belinda Lee(Walter and Eliza Hall Institute of Medical Research), N. C. Tebbutt(Austin Health), Natalie Rainey(Queensland Government), Geoffrey Chong(Northern Health), Ayesha Saqib(Epworth Hospital), Mun Sem Liew(R&G Associates), Matthew E. Burge(Royal Brisbane and Women's Hospital), Stephanie Hui-Su Lim(Camden and Campbelltown Hospitals), Rachel Wong(Eastern Health), Louise M. Nott(Royal Hobart Hospital), Sarah Sutherland(Chris O’Brien Lifehouse), Sue-Anne McLachlan(St Vincent's Hospital Melbourne), Shu Fen Wong(Barwon Health), Grace Kim(Walter and Eliza Hall Institute of Medical Research)
Cited by 0
Related Papers
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
|JAMA Oncology|2019|694
Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)
|Translational Lung Cancer Research|2019|392
Factors Associated with Adverse Cardiovascular Events in Cancer Patients Treated with Bevacizumab
|Journal of Clinical Medicine|2020|30
Prostate Cancer: Cases of Rare Presentation and Rare Metastasis
|Case Reports in Oncology|2015|19
A Rare Case of Paclitaxel and/or Trastuzumab Induced Acute Hepatic Necrosis
|Case Reports in Oncological Medicine|2015|18